Moore et al., 2006 - Google Patents
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1Moore et al., 2006
View PDF- Document ID
- 12143327607994031180
- Author
- Moore P
- Crooks E
- Porter L
- Zhu P
- Cayanan C
- Grise H
- Corcoran P
- Zwick M
- Franti M
- Morris L
- Roux K
- Burton D
- Binley J
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Human immunodeficiency virus type 1 (HIV-1) neutralizing antibodies are thought be distinguished from nonneutralizing antibodies by their ability to recognize functional gp120/gp41 envelope glycoprotein (Env) trimers. The antibody responses induced by …
- 101710023234 Segment 5 0 title abstract description 148
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Moore et al. | Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1 | |
| Tong et al. | HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes | |
| Binley et al. | Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization | |
| Sanders et al. | HIV-1 neutralizing antibodies induced by native-like envelope trimers | |
| Alam et al. | Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection | |
| Astronomo et al. | A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120 | |
| Srivastava et al. | Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus | |
| Binley et al. | Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions | |
| EP2765138B1 (en) | HIV-1 envelope glycoprotein | |
| AU625970B2 (en) | Hiv-3 retrovirus and its use | |
| Selvarajah et al. | Comparing antigenicity and immunogenicity of engineered gp120 | |
| Davenport et al. | Binding interactions between soluble HIV envelope glycoproteins and quaternary-structure-specific monoclonal antibodies PG9 and PG16 | |
| Derby et al. | Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection | |
| Krachmarov et al. | Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking | |
| Yang et al. | Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1 | |
| Edinger et al. | Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein | |
| Crooks et al. | Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization | |
| Sellhorn et al. | Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins | |
| US20130101617A1 (en) | Env trimer immunogens | |
| US10005819B2 (en) | Method of purifying authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag | |
| Leaman et al. | In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1 | |
| Crooks et al. | Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization | |
| Gonelli et al. | Immunogenicity of HIV-1-based virus-like particles with increased incorporation and stability of membrane-bound Env | |
| Tong et al. | Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein | |
| Narayan et al. | Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate |